RFAI:NASDAQRF Acquisition Corp II Analysis
Data as of 2026-04-28 - not real-time
$10.92
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
RFAI trades at $10.92 just above its 20‑day SMA (10.92) and 50‑day SMA (10.89), indicating a tight bullish alignment. The RSI sits at 53.9, suggesting neutral momentum, while the MACD histogram is slightly negative, hinting at short‑term bearish pressure. Support is anchored at $10.89 and resistance at $11.44, with volume trending downwards and daily volume barely reaching 10 shares, raising liquidity concerns.
Fundamentally, the SPAC reports zero revenue, negative operating and free cash flow, a high trailing PE of 45.5 versus an industry average of 17.5, and a negative price‑to‑book of -19.85, all of which point to an overvalued status. However, the company holds $337k in cash and operates in a sector (technology‑focused SPACs) that benefits from the current “Extreme Greed” market sentiment (FGI 89.25).
Fundamentally, the SPAC reports zero revenue, negative operating and free cash flow, a high trailing PE of 45.5 versus an industry average of 17.5, and a negative price‑to‑book of -19.85, all of which point to an overvalued status. However, the company holds $337k in cash and operates in a sector (technology‑focused SPACs) that benefits from the current “Extreme Greed” market sentiment (FGI 89.25).
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish price alignment with short‑term SMAs
- Negative MACD histogram indicating near‑term downside pressure
- Severe liquidity constraints due to minimal trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Absence of operating revenue and negative cash flows
- High PE relative to industry peers
- Potential upside if a credible technology merger materializes
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Cash reserve provides runway for a business combination
- Targeted sectors (AI, quantum, biotech) have strong growth prospects
- Current market sentiment (Extreme Greed) may reward successful SPAC outcomes
Key Metrics & Analysis
Financial Health
P/E Ratio45.5
ROA-0.91%
P/B Ratio-19.9
Op. Cash Flow$-561403
Free Cash Flow$-150082
Industry P/E17.5
Technical Analysis
TrendBullish
RSI53.9
Support$10.89
Resistance$11.44
MA 20$10.92
MA 50$10.89
MA 200$10.74
MACDBearish
VolumeDecreasing
Fear & Greed Index89.25
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.00
Volatility2.54%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.